Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.
2.
3.

Bacteroidetes Neurotoxins and Inflammatory Neurodegeneration.

Zhao Y, Lukiw WJ.

Mol Neurobiol. 2018 Dec;55(12):9100-9107. doi: 10.1007/s12035-018-1015-y. Epub 2018 Apr 10. Review.

PMID:
29637444
4.

Microbiome-Derived Lipopolysaccharide Enriched in the Perinuclear Region of Alzheimer's Disease Brain.

Zhao Y, Cong L, Jaber V, Lukiw WJ.

Front Immunol. 2017 Sep 4;8:1064. doi: 10.3389/fimmu.2017.01064. eCollection 2017.

5.

Secretory Products of the Human GI Tract Microbiome and Their Potential Impact on Alzheimer's Disease (AD): Detection of Lipopolysaccharide (LPS) in AD Hippocampus.

Zhao Y, Jaber V, Lukiw WJ.

Front Cell Infect Microbiol. 2017 Jul 11;7:318. doi: 10.3389/fcimb.2017.00318. eCollection 2017. Review.

6.

Run-on gene transcription in human neocortical nuclei. Inhibition by nanomolar aluminum and implications for neurodegenerative disease.

Lukiw WJ, LeBlanc HJ, Carver LA, McLachlan DR, Bazan NG.

J Mol Neurosci. 1998 Aug;11(1):67-78.

PMID:
9826787
7.
8.

microRNA (miRNA) speciation in Alzheimer's disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF).

Alexandrov PN, Dua P, Hill JM, Bhattacharjee S, Zhao Y, Lukiw WJ.

Int J Biochem Mol Biol. 2012;3(4):365-73. Epub 2012 Dec 24.

10.

Activation of migration of endogenous stem cells by erythropoietin as potential rescue for neurodegenerative diseases.

Khairallah MI, Kassem LA, Yassin NA, Gamal el Din MA, Zekri M, Attia M.

Brain Res Bull. 2016 Mar;121:148-57. doi: 10.1016/j.brainresbull.2016.01.007. Epub 2016 Jan 21.

PMID:
26802509
11.

Regulation of neurotropic signaling by the inducible, NF-kB-sensitive miRNA-125b in Alzheimer's disease (AD) and in primary human neuronal-glial (HNG) cells.

Zhao Y, Bhattacharjee S, Jones BM, Hill J, Dua P, Lukiw WJ.

Mol Neurobiol. 2014 Aug;50(1):97-106. doi: 10.1007/s12035-013-8595-3. Epub 2013 Nov 29. Review.

12.

Microglial derived tumor necrosis factor-α drives Alzheimer's disease-related neuronal cell cycle events.

Bhaskar K, Maphis N, Xu G, Varvel NH, Kokiko-Cochran ON, Weick JP, Staugaitis SM, Cardona A, Ransohoff RM, Herrup K, Lamb BT.

Neurobiol Dis. 2014 Feb;62:273-85. doi: 10.1016/j.nbd.2013.10.007. Epub 2013 Oct 17.

13.
15.

Neuroprotection by association of palmitoylethanolamide with luteolin in experimental Alzheimer's disease models: the control of neuroinflammation.

Paterniti I, Cordaro M, Campolo M, Siracusa R, Cornelius C, Navarra M, Cuzzocrea S, Esposito E.

CNS Neurol Disord Drug Targets. 2014;13(9):1530-41.

PMID:
25106636
16.

Alzheimer's disease.

De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV.

Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Review.

PMID:
23225010
17.

Microbiome-Mediated Upregulation of MicroRNA-146a in Sporadic Alzheimer's Disease.

Zhao Y, Lukiw WJ.

Front Neurol. 2018 Mar 19;9:145. doi: 10.3389/fneur.2018.00145. eCollection 2018.

18.

Neuronal Toll-like receptor 4 signaling induces brain endothelial activation and neutrophil transmigration in vitro.

Leow-Dyke S, Allen C, Denes A, Nilsson O, Maysami S, Bowie AG, Rothwell NJ, Pinteaux E.

J Neuroinflammation. 2012 Oct 3;9:230. doi: 10.1186/1742-2094-9-230.

19.

Interleukin-10 Protection against Lipopolysaccharide-Induced Neuro-Inflammation and Neurotoxicity in Ventral Mesencephalic Cultures.

Zhu Y, Chen X, Liu Z, Peng YP, Qiu YH.

Int J Mol Sci. 2015 Dec 28;17(1). pii: E25. doi: 10.3390/ijms17010025.

20.

[Pro-inflammatory cytokines in Alzheimer's disease].

Stamouli EC, Politis AM.

Psychiatriki. 2016 Oct-Dec;27(4):264-275. doi: 10.22365/jpsych.2016.274.264. Review. Greek, Modern.

PMID:
28114090

Supplemental Content

Support Center